Leslie's, Inc. (LESL) Prices 15.82M Share Secondary Offering at $22/sh

UPDATE: Berenberg Upgrades Leslie's (LESL) to Buy

(Updated - September 14, 2021 6:36 AM EDT)

Berenberg analyst Rudy Yang upgraded Leslie's (NASDAQ: LESL) from Hold to Buy with a price target of $30 (from $28).

The analyst commented, "We are upgrading Leslie's to a Buy rating (from Hold) and increasing our price target to $30... More

Pre-Open Stock Movers 09/13: (ITMR) (LPTX) (BLU) Higher; (MDXG) (FAMI) (VALN) Lower (more...)

Today's Pre-Open Stock Movers:

MiMedx Group, Inc. (Nasdaq: MDXG) 53% LOWER; announced top-line results from two late-stage musculoskeletal clinical trials of the Companys micronized dehydrated Human Amnion Chorion Membrane (mdHACM): a Phase 2B clinical trial for the treatment of Knee Osteoarthritis (KOA) and a Phase 3 clinical trial for the treatment of Plantar Fasciitis (PF).

Farmmi, Inc. (NASDAQ: FAMI) 49% LOWER; announced the pricing of an underwritten public offering of ordinary shares and pre-funded warrants to purchase ordinary shares ("Offering"), with... More

Leslie's, Inc. (LESL) Announces 13M Share Secondary Offering

Leslies, Inc. (Nasdaq: LESL) today announced that certain of the Companys stockholders (the Selling Stockholders), intend to offer for sale in an underwritten secondary offering 13,000,000 shares of the Companys common stock (the Offering). The Selling Stockholders will also grant the underwriters a 30-day option to purchase up to an additional 1,950,000 shares of common stock. The Selling Stockholders will receive all of the proceeds from the Offering. Leslies is not offering any shares of its common stock in the Offering and will not receive any... More

Leslie's, Inc. (LESL) Files 13M Share Secondary Offering

Leslie's, Inc. (NASDAQ: LESL) has filed 13,000,000 secondary share offering by a selling stockholder.